Pharming Group NV
LSE:0QCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharming Group NV
LSE:0QCO
|
NL |
|
K
|
Kewal Kiran Clothing Ltd
NSE:KKCL
|
IN |
|
E
|
Euro Sun Mining Inc
SWB:OL11
|
CA |
Wall St Price Targets
0QCO Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for 0QCO is 2.2827 EUR with a low forecast of 1.8389 EUR and a high forecast of 2.7614 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QCO's stock price target?
Price Target
2.2827
EUR
According to Wall Street analysts, the average 1-year price target for 0QCO is 2.2827 EUR with a low forecast of 1.8389 EUR and a high forecast of 2.7614 EUR.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.
What is the Gross Profit forecast for Pharming Group NV?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 5 years is 36%.
What is the Pre-Tax Income forecast for Pharming Group NV?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
112%
The compound annual growth rate for Net Income over the next 5 years is 112%.
